Article
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
25 Feb 2022
Abstract excerpt
Viral infections are a common cause of morbidity worldwide. The emergence of Coronavirus Disease 2019 (COVID-19) has led to more attention to viral infections and finding novel therapeutics. The CRISPR-Cas9 system has been recently proposed as a potential therapeutic tool for the treatment of viral diseases. Here, we review the research progress in the use of CRISPR-Cas technology for treating viral infections,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
